Healthcare-associated pneumonia: Approach to management

Andrew Labelle, Marin H. Kollef

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Abstract

Healthcare-associated pneumonia patients have worse outcomes and a different microbiologic profile than those with community-acquired pneumonia, including a greater risk for multidrug-resistant (MDR) organism infection. Risks include hospitalization for 2 or more days within 90 days, presentation from a nursing home or long-term care facility, attending a hospital or hemodialysis clinic, receiving intravenous therapy within 30 days, and immunosuppression. Ability to predict infection with MDR organisms varies, and the relative frequency of MDR organisms varies by geographic region. Initial treatment is broad-spectrum empiric antibiotics.

Original languageEnglish
Pages (from-to)507-515
Number of pages9
JournalClinics in Chest Medicine
Volume32
Issue number3
DOIs
StatePublished - Sep 1 2011

Keywords

  • Antibiotic therapy
  • Community-acquired
  • Healthcare-associated
  • Pneumonia
  • Risk factors

Fingerprint Dive into the research topics of 'Healthcare-associated pneumonia: Approach to management'. Together they form a unique fingerprint.

Cite this